Delhi HC rejects Vimal Elaichi maker’s plea over notices to celebrity endorsers
The Delhi High Court dismissed PB Agro LLP’s challenge to Maharashtra FDA notices issued to Shah Rukh Khan, Ajay Devgn and Tiger Shroff over alleged surrogate advertising for Vimal Pan Masala, citing lack of territorial jurisdiction.
What happened
Delhi High Court dismissed Vimal Elaichi maker PB Agro LLP’s challenge to Maharashtra FDA notices against celebrity endorsers over alleged surrogate advertising
Key facts
- 15 days
- August 11
Why this matters
Treat celebrity endorsement structures and surrogate-advertising exposure as core diligence items in deals involving regulated or reputation-sensitive consumer brands.
What to watch
- Maharashtra FDA issuing follow-up summons, show-cause notices, penalties or referrals after celebrity and company responses.
- A challenge filed in the Bombay High Court or any appellate move against the Delhi High Court order.
- Evidence that advertising uses common logos, color schemes, taglines, celebrity films or retail placement connecting Vimal Elaichi to Vimal Pan Masala.
- ASCI, CCPA, Union health authorities or other state FDAs opening parallel inquiries into surrogate advertisements.
- Any endorsement pause, campaign withdrawal, contract renewal change or public statement from Shah Rukh Khan, Ajay Devgn or Tiger Shroff.
- PB Agro may respond substantively to Maharashtra FDA notices, pursue relief before a Maharashtra court, or revise campaign disclaimers and product-brand separation.
- Celebrity endorsers are likely to seek legal opinions, document due diligence and add indemnity, morality and regulatory-compliance protections to endorsement contracts.
- Vimal may reduce use of the same ambassadors across elaichi and pan masala-linked promotions while reassessing packaging, point-of-sale material and media buys.
- Competing regulated-category brands may pre-emptively audit surrogate-brand architecture and celebrity campaigns.